Cytotoxic linear peptide
Need Assistance?
  • US & Canada:
    +
  • UK: +

Cytotoxic linear peptide

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Cytotoxic linear peptide is an antibacterial peptide isolated from Pandinus cavimanus.

Category
Functional Peptides
Catalog number
BAT-012650
Molecular Formula
C69H108N16O16S
Molecular Weight
1449.77
Synonyms
NDBP-5; Phe-Leu-Gly-Gly-Leu-Trp-Lys-Ala-Met-Ser-Asn-Leu-Leu
Purity
97.7%
Sequence
FLGGLWKAMSNLL
Storage
Store at -20°C
1. Antimicrobial, Insecticidal and Cytotoxic Activity of Linear Venom Peptides from the Pseudoscorpion Chelifer cancroides
Jonas Krämer, Tim Lüddecke, Michael Marner, Elena Maiworm, Johanna Eichberg, Kornelia Hardes, Till F Schäberle, Andreas Vilcinskas, Reinhard Predel Toxins (Basel). 2022 Jan 14;14(1):58. doi: 10.3390/toxins14010058.
Linear cationic venom peptides are antimicrobial peptides (AMPs) that exert their effects by damaging cell membranes. These peptides can be highly specific, and for some, a significant therapeutic value was proposed, in particular for treatment of bacterial infections. A prolific source of novel AMPs are arthropod venoms, especially those of hitherto neglected groups such as pseudoscorpions. In this study, we describe for the first time pharmacological effects of AMPs discovered in pseudoscorpion venom. We examined the antimicrobial, cytotoxic, and insecticidal activity of full-length Checacin1, a major component of the Chelifer cancroides venom, and three truncated forms of this peptide. The antimicrobial tests revealed a potent inhibitory activity of Checacin1 against several bacteria and fungi, including methicillin resistant Staphylococcus aureus (MRSA) and even Gram-negative pathogens. All peptides reduced survival rates of aphids, with Checacin1 and the C-terminally truncated Checacin11-21 exhibiting effects comparable to Spinosad, a commercially used pesticide. Cytotoxic effects on mammalian cells were observed mainly for the full-length Checacin1. All tested peptides might be potential candidates for developing lead structures for aphid pest treatment. However, as these peptides were not yet tested on other insects, aphid specificity has not been proven. The N- and C-terminal fragments of Checacin1 are less potent against aphids but exhibit no cytotoxicity on mammalian cells at the tested concentration of 100 µM.
2. IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis
L Dai, A Yasuda, H Naoki, G Corzo, M Andriantsiferana, T Nakajima Biochem Biophys Res Commun. 2001 Aug 31;286(4):820-5. doi: 10.1006/bbrc.2001.5472.
A novel cytotoxic linear peptide, IsCT, was characterized from scorpion Opisthacanthus madagascariensis. It is a linear peptide with a molecular weight of 1501.9 Da composed of 13 amino acid residues without cysteines. MS/MS analysis showed that its C-terminal is amidated. The identity of IsCT is re-confirmed by comparing the chemical synthesized peptide with the natural one. IsCT demonstrated antimicrobial activity against both gram-positive and gram-negative bacteria and hemolytic activity to sheep red blood cells. Also, it can release histamine from rat peritoneal mast cells. The CD absorption suggested that IsCT had an alpha-helix configuration in aqueous TFE. IsCT is one of the shortest natural cytotoxic peptides described, and it will be a suitable model for studying peptide-lipid interactions.
3. Peptide-Drug Conjugate: A Novel Drug Design Approach
Liang Ma, Chao Wang, Zihao He, Biao Cheng, Ling Zheng, Kun Huang Curr Med Chem. 2017;24(31):3373-3396. doi: 10.2174/0929867324666170404142840.
More than 100 years ago, German physician Paul Ehrlich first proposed the concept of selectively delivering "magic bullets" to tumors through targeting agents. The targeting therapy with antibody-drug conjugates (ADCs) and peptide-drug conjugate (PDCs), which are usually composed of monoclonal antibodies or peptides, toxic payloads and cleavage/ noncleavage linkers, has been extensively studied for decades. The conjugates enable selective delivery of cytotoxic payloads to target cells, which results in improved efficacy, reduced systemic toxicity and improved pharmacokinetics (PK)/pharmacodynamics (PD) compared with traditional chemotherapy. PDC and ADC share similar concept, but with vastly different structures and properties. Humanized antibodies introduce high specificity and prolonged half-life, while small molecule weight peptides exhibit higher drug loading and enhanced tissue penetration capacity, and the flexible linear or cyclic peptides are also modified more easily. In this review, the principles of design, synthesis approaches and the latest advances of PDCs are summarized.
Online Inquiry
Verification code
Inquiry Basket